New program aims to boost opioid treatment for pregnant women
NCT ID NCT04527926
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 22 times
Summary
This study tests a training program for prenatal healthcare providers to help them use proven treatments for opioid use disorder during pregnancy. Researchers will look at how the program affects the use of medication-assisted treatment and health outcomes for mothers and babies. About 1,000 patients' records will be reviewed, and a small group of pregnant women will also be interviewed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.